Sign in
4

Changes in Ownership

ArriVent BioPharma, Inc. Filed Acc 0001104659-24-008796

Director bought 444,444 shares at $18.00 ($7,999,992)

  • Director acquired 1,252,308 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
HEALY JAMES Director 2024-01-30 Conversion +1,252,308 1,252,308 I: show line 1 in the form
HEALY JAMES Director 2024-01-30 Purchase +444,444 $18.00 $7,999,992 1,696,752 I: show line 2 in the form
Open-market purchases · 444,444 sh · avg $18.00 · $7,999,992

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
HEALY JAMES Director 2024-01-30 Conversion · Series B Preferred Stock −1,252,308 0 I: show line 3 in the form
Loading xslF345X05/tm244611-2_4seq1.xml…